Parish P. Sedghizadeh, D.D.S., M.S.
Associate Professor of Clinical Dentistry
University of Southern California
University of Southern California
Los Angeles, California, USA
2:00 p.m.
Friday, June 25, 2021
International Academy of Endodontics, Annual Meeting
The Scottsdale Princess Resort
Scottsdale, Arizona, USA
“Hard Tissue Pathology of Significance to the Endodontist with an Emphasis on CBCT Imaging"
This talk will discuss hard tissue conditions relevant to the practice of Endodontics with an emphasis on applications of CBCT imaging including pathology diagnosis.
Topics:
Radiographic findings and parameters in hard tissue pathology
Developmental, reactive, and neoplastic conditions affecting the jawbones
Applications of CBCT imaging in Endodontics
Learning Objectives:
- Know when to use CBCT imaging in clinical practice
- Know how to identify and describe pathology on imaging studies
- Know how to diagnose radiographic pathology encountered in clinical practice
Affiliations:
Associate Professor, University of Southern California
About the Presenter:
Dr. Parish P. Sedghizadeh is an Associate Professor of Clinical Dentistry at the University of Southern California (USC), Herman Ostrow School of Dentistry, and Director of the USC Center for Biofilms research laboratory. Dr. Sedghizadeh serves as the Section Chair of Diagnostic Sciences at the Herman Ostrow School of Dentistry and is the Director of the hybrid Oral Pathology and Radiology Program. He completed his undergraduate training and Bachelor of Science degree at UCLA, his Doctor of Dental Surgery degree at USC, and specialty training in oral and maxillofacial pathology and a Master of Science degree in oral biology at The Ohio State University. As a clinician-scientist, Dr. Sedghizadeh conducts research, publishes, consults, and teaches oral pathology, radiology, surgery, pain, and medicine with an active intramural clinical practice. He has over 80 peer-reviewed publications, and his research laboratory and clinical research projects at USC focus on the characterization and treatment of microbial biofilm infections, particularly osteomyelitis and osteonecrosis of the jaw where he has developed and tested novel bisphosphonate-antibiotic conjugates to target bone biofilm infections.